Zhaoxia Qu

8PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 08, 2026
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

|May 13, 2026
AKT Signaling Differentially Regulates the Expression of Two Evolutionarily Conserved Wnt5a Isoforms in Lung Mesenchymal Cells.

|Sep 26, 2025
PDLIM2 Repression: A Common Mechanism in Viral Lung Infection.

Feng Gao, Yongzheng W Chen, Steven D Shapiro

|Dec 24, 2024
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2.

Fan Sun, Pengrong Yan, Yadong Xiao

|Jul 31, 2024
PDLIM2 is a novel E5 ubiquitin ligase enhancer that stabilizes ROC1 and recruits the ROC1-SCF ubiquitin ligase to ubiquitinate and degrade NF-κB RelA.

Fan Sun, Gutian Xiao, Zhaoxia Qu

|May 09, 2024
NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.

Xinxin Song, Zhaoxia Qu

Pageof 2

Frequent Collaborators

2 joint publications

Hongqiao Zhang

1 joint publications

Feng Gao

1 joint publications

Changgong Li

1 joint publications

Karam Ashouri